Literature DB >> 2082185

5'-Heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated "C"-receptor and unique A-receptor messages.

L L Wei1, C Gonzalez-Aller, W M Wood, L A Miller, K B Horwitz.   

Abstract

Human progesterone receptors (PR) are thought to comprise two naturally occurring hormone-binding proteins: 94-kDa A-receptors and 120-kDa B-receptors. In this paper we present evidence for a third human PR, an N-terminally truncated, 45- to 50-kDa species, termed the C-receptor. To determine the translational origin of B- and A-receptors we mapped the multiple messages that code for human PR by Northern blot analyses, using a series of oligonucleotides and cDNA fragment probes corresponding to different regions of the PR message. In addition to the six transcripts of 2.5, 3.2, 4.5, 5.2, 6.1, and 11.4 kilobases (kb) originally described, we found that the 11.4-kb species is a complex of four bands that we have termed I-IV. Analysis of poly(A)+ RNA derived from T47Dv human breast cancer cells using a variety of 5'-specific probes has identified three separate structural classes of human PR transcripts, indicating extensive 5'-termini heterogeneity. Class A messages, the 2.5- and 5.2-kb species, lack the sequences surrounding AUGB (codon 1), which is the translation initiation site for B-receptors, but contain AUGA (codon 165), the initiation site for A-receptors, and, therefore, potentially encode only the latter. Class B messages, consisting of the 3.2-, 4.5-, and 6.1-kb species as well as bands I and II of the 11.4-kb complex contain both AUGB and AUGA and could encode both receptor forms.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2082185     DOI: 10.1210/mend-4-12-1833

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  26 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

Review 2.  Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters.

Authors:  Shaila Mani; Wendy Portillo
Journal:  Front Neuroendocrinol       Date:  2010-01-29       Impact factor: 8.606

Review 3.  Progesterone receptors, their isoforms and progesterone regulated transcription.

Authors:  Britta M Jacobsen; Kathryn B Horwitz
Journal:  Mol Cell Endocrinol       Date:  2011-09-17       Impact factor: 4.102

Review 4.  Progestin receptor subtypes in the brain: the known and the unknown.

Authors:  Shaila Mani
Journal:  Endocrinology       Date:  2008-02-28       Impact factor: 4.736

5.  Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation.

Authors:  Hany Abdel-Hafiz; Michelle L Dudevoir; Kathryn B Horwitz
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

Review 6.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

Review 7.  The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease.

Authors:  A Sasha Tait; Cherie L Butts; Esther M Sternberg
Journal:  J Leukoc Biol       Date:  2008-07-29       Impact factor: 4.962

Review 8.  Minireview: fetal-maternal hormonal signaling in pregnancy and labor.

Authors:  Carole R Mendelson
Journal:  Mol Endocrinol       Date:  2009-03-12

9.  The cytoplasmic 60 kDa progesterone receptor isoform predominates in the human amniochorion and placenta at term.

Authors:  Anthony H Taylor; Penny C McParland; David J Taylor; Stephen C Bell
Journal:  Reprod Biol Endocrinol       Date:  2009-03-13       Impact factor: 5.211

Review 10.  Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression.

Authors:  Katherine M Scarpin; J Dinny Graham; Patricia A Mote; Christine L Clarke
Journal:  Nucl Recept Signal       Date:  2009-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.